当前位置:首页>其他试剂>Delivector™ Avertin (小鼠)

产品名称:Delivector™ Avertin (小鼠)

英文名称:Delivector™ Avertin (mice)

产品货号:DW3100

产品包装:10ml*5

产品价格:280

保存温度:4℃避光

保质期:1年

说明书下载

产品简介:

  1、本品阿佛丁(Avertin)是即用型的无菌麻醉剂,其有效成分为三溴乙醇(Tribromoethanol,TBE),同时也叫阿佛丁,是非管制药物,

  2、曾被推荐作为转基因鼠传代有关的外科手术的麻醉剂。

  3、适用于孕鼠实验,不影响妊娠,也不影响胎鼠活性。

  4、使用时腹腔注射,简单方便,麻醉起效时间<5min,维持时间在24~90min范围内,仅用于啮齿类动物(小鼠)麻醉。

 

产品目录:

产品货号

产品名称

产品规格

   DW3106

Delivector™ Avertin (小鼠)

10ml

    DW3100

Delivector™ Avertin (小鼠)

10ml*5

     DW3101

Delivector™ Avertin (小鼠)

    10ml*10

     DW3120

Delivector™ Avertin (大鼠)

    10ml*10

    DW3116

Delivector™ Avertin (兔子)

     10ml*10

 

产品优势:

· 优于水合氯醛

· 适用于孕鼠麻醉

· 麻醉起效时间短:<5min

· 麻醉维持时间长:24~90min

· Delivector™ Avertin能通过伦理认证,发SCI认可麻醉剂。

 

麻醉时间验证表:

公司验证结果

品系

周龄

注射剂量

给药方式

起效时间

麻醉时间

C57BL/6

6-8周龄

20 ul/g

右腹腔注射

小于2min

30-90min

BALB/c

6-8周龄

20 ul/g

右腹腔注射

小于2min

30-90min

以上为我们验证时使用常用剂量,小/大鼠周龄不同或个体差异,使用量需根据实际情况自行调整,如果需要延长麻醉时间,可按初始剂量1/3补打,请实验者根据需求进行预实验。

 

产品应用:   仅用于啮齿类动物(小鼠)麻醉。

 

实验验证:(详情请见官网:www.dowobio.com,视频号有教学视频)

1、直结肠原位瘤模型的构建

2、脾脏转移瘤模型的构建

3、胰腺癌原位瘤及转移瘤模型的构建

4、灌胃实验

5、小动物活体成像等;更多专业验证,可联系技术咨询

 

保存方法:常温运输,4度避光保存。

 

注意事项:

· 开封后推荐在2周内使用。长时间存储成分会析出或分解,造成麻醉效果下降,甚至腹膜炎。使用前请务必确定标签上保质期,并观察是否变色或有结晶析出。如果有晶体析出,可以37度水浴溶解。正式实验前请先进行预实验。

· 推荐麻醉剂量:4周左右小鼠按16μl/g计算,6周左右小鼠按18μl/g计算,8周以上小鼠按20μl/g计算,(此为推荐使用量可根据实际情况进行调整),如需快速苏醒可用加热垫提高小鼠环境温度。

· 仅用于科研(非临床科研研究)。

 

本产品在文章中的写法:

英文: Dowobio (Shanghai ,China)

中文: 上海多沃生物科技有限公司  Dowobio,上海

 

文章奖励:

1、写法:

中文:上海多沃生物科技有限公司  Dowobio,上海  

英文:  Dowobio (shanghai,China)

2、奖励政策:

1、10分以上的SCI  1000元现金

2、5-10分的SCI    500元现金

3、0-5分的SCI      200元现金

4、中文文章          100元现金

奖励说明:申请人必须为文章第一作者或在通讯

 

文  献:

2026年部分文献及影响因子

1、Synergistic disruption of blood-brain barrier and neuroimmune homeostasis by sleep-related environmental pollutants drives sleep disorders: an integrated computational and experimental study (Environment International   IF:9.6)
2、Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation (SCIENTIFIC REPORTS   IF:3.9)

3、Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma (Drug Resistance Updates    IF: 21.7)

4、Ramulus mori (Sangzhi) alkaloids improve intestinal oxidative damage and inflammation in DHEA-induced polycystic ovary syndrome rats via gut microbiota and metabolite modulation(Frontiers in Pharmacology  IF:4.8)

5、Asiatic Acid-Loaded Hydrogel Ameliorates Diabetic Periodontitis via Mitophagy-Mediated M2 Macrophage Polarization (ACS Omega IF:4.3)

2025年部分文献及影响因子

1、The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma   (FBL  2024 IF:3.4)

2、HIF1α/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson’s disease   (Journal of Neurorestoratology   2024   IF:3.1)

3、Network pharmacology analysis and animal experiment validation of inflammation inhibition by Swertiamarin in treating Ulcerative colitis   (Naunyn-Schmiedeberg's Archives of Pharmacology  2025  IF:3.1)

4、PD-L1 and ICAM1 over expression empowers immunoregulation of mesenchymal stromal cells to improve the autoimmune hepatitis treatment efficacy  (advanced science  2025 IF:14.1)

5、Isoform switch of CD47 provokes macrophage-mediated pyroptosis in ovarian cancer  (npg precision oncology  2023 IF:6.8)

6、MTFR2-Mediated Fission Drives Fatty Acid and Mitochondrial Co-Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis (advanced science  2025 IF:14.1)

7、Interleukin-37 modulates microglial phenotype and inhibits inffammatory response via the MyD88/NF-κB pathway in lipopolysaccharide-induced neuroinffammation  (Inffammation Research  2024  IF: 4.8)
8、Sleep Deprivation Aggravates Periodontitis Through Trigeminal-Periodontal Neuroimmune Pathway Mediated by the AChE-ACh-α7nAChR Axis    (advanced science  2025 IF:14.1)
9、Nanotuner targeting mitochondrial redox and iron homeostasis imbalance for the treatment of acute liver injury  (Theranostics   2025  IF:13.3)
10、TREM-1 Promotes Microglial Pyroptosis and Mitochondrial Fission in Intracerebral Hemorrhage via the PI3K/AKT Pathway (FASEB J   2025  IF4.2)
11、 Small extracellular vesicles derived from human umbilical cord mesenchymal stem cells attenuate photoaging by modulating the GATA2/PZP/GRP75 axis(Cellular And Molecular Life Sciences  2025  IF:6.2)

12 、Apparent Diffusion Coefficient and Native T1 Mapping Histogram Analyses Reveal Tumor Proliferation and Microenvironment in Neuroblastoma Xenografts(Cancer Biomarkers 2025 IF:1.9)
13、Polyphenol-based self-assembled nanoparticles treating uveitis by inflammation-oxidative stress suppression (Materials Today Bio  2025 IF:10.2)
14 、Isoform switching of CD47 induces macrophage-initiated cancer cell pyroptosis   ( 
International Journal of Biological Sciences  2025  IF:10.0 )

15、A Comparative Study of the Effects of Nine CXCR3 Antagonists on Macrophage Function and the Treatment of Acute Lung Injury (FBL 2025  3.1)

16、The role and mechanism of irisin/NLRP3 signal in aerobic exercise ameliorating blood glucose homeostasis in pre-diabetic mice(PLoS ONE 2025 IF:2.6)

17、A Ce-MOFs-based melatonin delivery platform for treating  hepatic ischemia-reperfusion injury by interrupting the oxidation-inflammation loop(Nano Research 2025 IF:9.0)

18、Palmatine potentiates cefquinome efficacy against multidrug-resistant Escherichia coli via sulfur/taurine metabolism and oxidative stress modulatio (Frontiers in Microbiology 2025  IF:4.5)

19、Glucocorticoid inhibits lung cancer cells proliferation and migration by suppressing smad2/3 activation (Scientific Reports 2025 IF: 3.9)

20、A Comparative Study of the Effects of Nine CXCR3 Antagonists on Macrophage Function and the Treatment of Acute Lung Injury (FBL  2025  IF: 3.1)

21、Isoform switch of CD47 provokes macrophage-mediated pyroptosis in ovarian cancer (bioRxiv  2025 )

22、Carbon Dots via Synergistic Surface-Oxidation and Rigidity Enhancement with Ultra-Narrow Emission for Sensitive Near-Infrared Imaging and Sepsis Therapy (Advanced Functional Materials  2025 IF:19)

23、Co-Targeting Biomimetic Nanoparticles Alleviate Atherosclerosis by Inhibiting the Vicious Circle Between Inflammation and Lipids (International Journal of Nanomedicine 2025 IF:6.5)

24、CD44 is a nexus between prognosis and therapeutics for brain cancer management (Computers in Biology and Medicine 2025 IF:7)

25、Differential regulation of pruritic sensation and emotion by cannabinoid type 1 receptors on mPFC glutamatergic and GABAergic neurons (Acta Pharmacologica Sinica 2025 IF:8.5)

返回顶部